Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (223) Galzin (zinc acetate), Teva Pharmaceutical,
...Newly Approved Drug Therapies (223) Galzin (zinc acetate), Teva Pharmaceutical, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Galzin (zinc acetate) Company: Teva Pharmaceutical Approval Status: Approved January 1997 Treatment Area: Wilson’s disease General ...
View Page

2.  CenterWatch Clinical Industry Provider Profile(4157), SpectraCell Laboratories, Houston, TX
...Vitamin B3 (Niacin) • Vitamin B5 (Pantothenate) • Vitamin B6 • Vitamin B12 • Biotin • Folate • Calcium • Magnesium • Selenium • Zinc • Coenzyme Q • Cysteine • Glutathione • Asparagine • Carnitine • Glutamine • Serine • Lipoic Acid • Oleic Acid • Choline • Inositol • Fructose ...
View Page

3.  CenterWatch: Pharmacology/Toxicology Approved Drug Therapies
...October 1997 Antizol Injection ; Orphan Medical; Treatment for ethylene glycol poisoning, Approved December 1997 Galzin (zinc acetate) ; Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997 Kytril (granisetron) tablets ; SmithKline ...
View Page

4.  Study Posting (1570) Trial #156561, Neoplasms, Morristown, NJ
...hypersensitivity to Voraxaze (glucarpidase, carboxypeptidases) or to any of the excipients (lactose, Tris-HCl with zinc buffer). • Patients who have previously experienced allergic reactions to medicines containing lactose. Patients intolerant to ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (336), Chronic Fatigue Syndrome
...an open-label extension of a phase II study of PBT-1 (clioquinol) , a copper-zinc attenuator/amyloid-beta aggregation inhibitor for the treatment of Alzheimer’s disease (AD). Data ...
View Page

6.  CenterWatch: List of Newly Approved Drug Thearapies
...September 1997 Copaxone ; Teva Pharmaceutical; Treatment for relapsing-remitting multiple sclerosis, Approved January 1997 Galzin (zinc acetate) ; Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997 Imitrex (sumatriptan) injection and ...
...October 1997 Antizol Injection ; Orphan Medical; Treatment for ethylene glycol poisoning, Approved December 1997 Galzin (zinc acetate) ; Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997 Kytril (granisetron) tablets ; SmithKline ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (161), Head and Neck Cancer
...head and neck cancer who were treated by peritumoral injection of Multikine in addition to zinc sulfate, indomethacin and cyclopho-sphamide. Results were reported in Archives of Otolaryngology - Head & Neck Surgery ...
View Page

8.  CenterWatch: New Medical Therapies in Disease Category (100), Migraine and Cluster Headaches
...an open-label extension of a phase II study of PBT-1 (clioquinol) , a copper-zinc attenuator/amyloid-beta aggregation inhibitor for the treatment of Alzheimer’s disease (AD). Data ...
View Page

9.  CenterWatch: New Medical Therapies in Disease Category (11), Alzheimer's Disease
...an open-label extension of a phase II study of PBT-1 (clioquinol) , a copper-zinc attenuator/amyloid-beta aggregation inhibitor for the treatment of Alzheimer’s disease (AD). Data ...
View Page

10.  CenterWatch: New Medical Therapies in Disease Category (426), Colorectal Cancer
...head and neck cancer who were treated by peritumoral injection of Multikine in addition to zinc sulfate, indomethacin and cyclopho-sphamide. Results were reported in Archives of Otolaryngology - Head & Neck Surgery ...
View Page

11.  CenterWatch: Neurology Approved Drug Therapies
...September 1997 Copaxone ; Teva Pharmaceutical; Treatment for relapsing-remitting multiple sclerosis, Approved January 1997 Galzin (zinc acetate) ; Teva Pharmaceutical; Treatment for Wilson’s disease, Approved January 1997 Imitrex (sumatriptan) injection and ...
View Page